Veículo
Hekim.pro Doctor (Azerbaijão)
Em 2023: 0 notícias
Desde 1995: 45 notícias
Exposure to Chikungunya may offer partial cross-protection against Mayaro virus
Publicado em 05 dezembro 2021
A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus. The finding, presented in Journal of Virology, is based on experiments involving mice and blood serum from patients. According to the authors, this type of cross-protection may be one of the reasons for the absence of a major outbreak of Mayaro fever in Brazil. The study was supported by FAPESP.
In the experiments, mice [...]
-
Infection by Chikungunya produces partial immunity against Mayaro virus
Publicado em 03 dezembro 2021A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus. The finding, presented in Journal of Virology, is based on experiments involving mice and blood serum from patients. According to the authors, this type of cross-protection may be one of the reasons for the absence of a major outbreak of Mayaro fever in Brazil. The study was supported by FAPESP. In the experiments, mice [...]ver notícia -
Protein found in rattlesnake venom used for making a drug candidate to modulate blood clotting
Publicado em 02 dezembro 2021Researchers in Brazil and Belgium have developed a molecule of pharmaceutical interest from collinein-1, a protein found in rattlesnake venom. They used a technique called PEGylation to make the molecule, now called PEG-rCollinein-1, more stable in the organism and resistant to the immune system, obtaining a drug candidate to modulate blood clotting. An article reporting the results of the research has recently been published in the International Journal of Biological Macromolecules. The [...]ver notícia -
How often does SARS-CoV-2 infect alongside another viruses?
Publicado em 29 novembro 2021The diagnosis of the coronavirus disease 2019 (COVID-19) is normally achieved by either reverse-transcriptase polymerase chain reaction (RT-PCR) assay or lateral flow device testing. Many countries provide lateral flow devices to their citizens for free or subsidize the cost. Moreover, testing is required by several governments in order to travel internationally. However, this data only provides information on infection with severe acute respiratory syndrome coronavirus 2 [...]ver notícia -
Study Helps Understand Why Obesity Increases Risk Of Cardiovascular Complications In COVID-19
Publicado em 12 novembro 2021In COVID-19 patients, obesity is the factor most associated with the development of endothelial dysfunction, a condition in which the blood vessels become unable to contract and relax adequately, increasing the risk of events such as heart attacks, thrombosis (blood clotting), and stroke. Endothelium refers to the thin sheet of cells lining the walls of arteries and veins, as well as the inside of the heart. Endothelial cells release substances that control vascular relaxation and contraction, [...]ver notícia -
Change in vaccination strategy averted outbreak of urban yellow fever in São Paulo State
Publicado em 08 novembro 2021Yellow fever is a non-contagious viral disease with two transmission cycles, sylvatic (in wild animals) and urban. Sylvatic yellow fever circulates among monkeys, and in Brazil is transmitted by mosquitoes of the genera Haemagogus and Sabethes, which bite an infected monkey and then infect others. Urban yellow fever circulates among humans and is transmitted by the mosquito Aedes aegypti (human-mosquito-human). Brazil has had no urban yellow fever cases since 1942, but the sylvatic version can [...]ver notícia -
Highly abundant virus in humans could be a biomarker for COVID-19
Publicado em 05 novembro 2021Torquetenovirus (TTV) is one of the viruses most frequently found in the human organism. It is also common in monkeys and domestic animals. Its presence has not been associated with any known disease, but its excessive replication is a sign that something is wrong with the immune system. The correlation between high TTV load and immunosuppression has been used in medicine in certain contexts, such as monitoring transplant patients who take medication to prevent rejection of the transplanted [...]ver notícia -
Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose
Publicado em 30 outubro 2021The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal. The World Health Organization (WHO) currently recommends only prophylactic use of heparin for such patients. The prophylactic dose of the drug, prescribed mainly to prevent blood clots, is only a quarter of the therapeutic dose. [...]ver notícia -
COVID-19 affects transplant recipients differently, possible therapeutic approach suggested
Publicado em 05 outubro 2021Recipients of liver transplants who contracted COVID-19 recovered faster with less severe inflammation than heart or kidney transplant recipients, and some even did better than non-transplant patients, according to a study conducted at Hospital das Clínicas (HC), the hospital complex run by the University of São Paulo’s Medical School (FM-USP) in Brazil. An article describing the study and its main results is published in the journal Transplantology. The researchers [...]ver notícia -
Study reveals how saline solution can inhibit replication of SARS-CoV-2
Publicado em 21 setembro 2021Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic saline solution inhibits replication of SARS-CoV-2, the virus that causes COVID-19, and have elucidated the biochemical mechanism involved. An article reporting the research is published in ACS Pharmacology & Translational Science. The study was performed in the laboratory using human epithelial lung cells infected with the virus. If the strategy proves effective in clinical trials, it [...]ver notícia